Resumption of activity in gastroenterology departments. Recommendations by SEPD, AEEH, GETECCU and AEG

Gastroenterología y Hepatología (English Edition) - Tập 43 - Trang 332-347 - 2020
Javier Crespo1, Raúl Andrade2, Fernando Alberca de las Parras3, Francesc Balaguer4, Manuel Barreiro-de Acosta5, Luís Bujanda6, Ana Gutiérrez7, Francisco Jorquera8, Julio Iglesias-García9, Andrés Sánchez-Yagüe10, José Luis Calleja11
1President of SEPD, Head, Gastroenterology Department, Hospital Universitario Marqués de Valdecilla. Instituto de Investigación Valdecilla (IDIVAL). Medicine School. Universidad de Cantabria, Santander, Spain
2Presidente of AEEH, Head, Gastroenterology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain
3Head, Gastroenterology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
4Secretary of the Asociación Española de Gastroenterología (AEG), Department of Gastroenterology, Hospital Clínic, Barcelona, Spain
5President of GETECCU, IBD Unit, Gastroenterology Department, Hospital Clínico Universitario de Santiago, Santiago de Compostela, A Coruña, Spain
6President of the Asociación Española de Gastroenterología (AEG), Instituto Biodonostia, CIBERehd, Universidad del País Vasco (UPV/EHU) , San Sebastián, Guipúzcoa, Spain
7Vicenpresident of GETECCU, Gastroenterology Department, Hospital General Universitario de Alicante. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd). Instituto de Salud Carlos III, Alicante, Spain
8Head, Gastroenterology Department, Complejo Asistencial Universitario de León. IBIOMED. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd). Instituto de Salud Carlos III, León, Spain
9Head, Endoscopy Section, Gastroenterology Department, Hospital Clínico Universitario de Santiago, Santiago de Compostela, A Coruña, Spain
10Area Specialist, Gastroenterology Department, Hospital Costa del Sol, Marbella, Head, Gastroenterology Department, Hospital Vithas Xanit Internacional, Benalmádena, Málaga, Spain
11Vicepresident of AEEH, Head, Gastroenterology and Hepatology Department, Hospital Universitario Puerta de Hierro Majadahonda. Instituto de Investigación Biomédica IDIPHIM. Universidad Autónoma de Madrid, Majadahonda, Madrid, Spain

Tài liệu tham khảo

Crespo J, Iglesias-García J, Hinojosa del Val J, Ampuero Herrojo J, Pérez-Cuadrado Martínez E. Afectación en aparato digestivo por COVID 19. Ref:7128/2020 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032 2020, Protecting health care workers during the COVID-19 coronavirus outbreak-lessons from Taiwan's SARS response, Clin Infect Dis Li, 2020, Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2), Science, 368, 489, 10.1126/science.abb3221 2020, COVID-19: protecting health-care workers, Lancet, 395, 922, 10.1016/S0140-6736(20)30644-9 Flaxman, 2020, Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries, Imperial College London https://www.cochranelibrary.com/es/cdsr/doi/10.1002/14651858.CD013574/full/es?contentLanguage=es. Remuzzi, 2020, COVID-19 and Italy: what next?, Lancet, 10.1016/S0140-6736(20)30627-9 Terry, 2020 Ohannessian, 2020, Global telemedicine implementation and integration within health systems to fight the COVID-19 pandemic: a call to action, JMIR Public Health Surveill, 6, e18810, 10.2196/18810 Serper, 2020, Telemedicine in liver disease and beyond: can the COVID-19 crisis lead to action?, Hepatology, 10.1002/hep.31276 Rubin, 2020, Clinical practice update on management of inflammatory bowel disease during the COVID-19 pandemic: expert commentary, Gastroenterology, 10.1053/j.gastro.2020.04.012 Xiao, 2020, Evidence for gastrointestinal infection of SARS-CoV-2, Gastroenterology, 10.1053/j.gastro.2020.02.055 Wu, 2020, Prolonged presence of SARS-CoV-2 viral RNA in faecal samples, Lancet Gastroenterol Hepatol, 5, 434, 10.1016/S2468-1253(20)30083-2 Norsa, 2020, Uneventful course in IBD patients during SARS-CoV-2 outbreak in northern Italy, Gastroenterology, 10.1053/j.gastro.2020.03.062 Ferreira, 2020, 1st interview COVID-19 ECCO taskforce, J Crohn's Colitis Current Data Secure-IBD Database. https://covidibd.org/current-data/. BSG expanded consensus advice for the management of IBD during the COVID-19 pandemic. The British Society of Gastroenterology. https://www.bsg.org.uk/covid-19-advice/bsg-advice-for-management-of-inflammatory-bowel-diseases-during-the-covid-19-pandemic/. Published March 30, 2020 [accessed 31.03.20]. Rubin, 2020, AGA clinical practice update on management of inflammatory bowel disease during the COVID-19 pandemic: expert commentary, Gastroenterology, 10.1053/j.gastro.2020.04.012 Brake, 2020, Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19), J Clin Med, 9, 10.3390/jcm9030841 Zingone, 2020, Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak, Lancet Gastroenterol Hepatol, 10.1016/S2468-1253(20)30085-6 Mazza, 2020, A fatal case of COVID-19 pneumonia occurring in apatient with severe acute ulcerative colitis., Gut, 10.1136/gutjnl-2020-321183 Lamb, 2019, British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults, Gut, 68, s1, 10.1136/gutjnl-2019-318484 Kemp, 2018, Second N-ECCO consensus statements on the european nursing roles in caring for patients with crohn's disease or ulcerative colitis, J Crohns Colitis, 12, 760, 10.1093/ecco-jcc/jjy020 Aguas, 2016, Telemedicine in inflammatory bowel disease: opportunity ahead, Inflamm Bowel Dis, 22, E4, 10.1097/MIB.0000000000000676 Calvet, 2014, Delphi consensus statement: quality indicators for inflammatory bowel disease comprehensive care units, J Crohns Colitis, 8, 240, 10.1016/j.crohns.2013.10.010 Van Assche, 2012, Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial, Gut, 61, 229, 10.1136/gutjnl-2011-300755 Lin, 2020, Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection, Gut, 10.1136/gutjnl-2020-321013 Chiu, 2020, Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements), Gut, 10.1136/gutjnl-2020-321185 Han, 2020, Preventing the spread of COVID-19 in digestive endoscopy during the resuming period: meticulous execution of screening procedures, Gastrointest Endosc, 10.1016/j.gie.2020.03.3855 Zhang, 2020, Suggestions for infection prevention and control in digestive endoscopy during current 2019-nCoV pneumonia outbreak in Wuhan, Hubei province, China, Endoscopy, 52, 312, 10.1055/a-1128-4313 Cheung, 2020, Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong Cohort and systematic review and meta-analysis, Gastroenterology Sociedad Española de Patología Digestiva, Asociación Española de Gastroenterología, 2020, Recommendations by the SEPD and AEG, both in general and on the operation of gastrointestinal endoscopy and gastroenterology units, concerning the current SARS-CoV-2 pandemic (March, 18), Rev Espanola Enfermedades Dig Organo Of Soc Espanola Patol Dig ESGE and ESGENA Position Statement on gastrointestinal endoscopy and the COVID-19 pandemic – European Society of Gastrointestinal Endoscopy (ESGE) [Internet]. Available from: https://www.esge.com/esge-and-esgena-position-statement-on-gastrointestinal-endoscopy-and-the-covid-19-pandemic/ [cited 13.04.20]. Repici, 2020, Coronavirus (COVID-19) outbreak: what the department of endoscopy should know, Gastrointest Endosc, 10.1016/j.gie.2020.03.019 Beilenhoff, 2018, Endoscopy, 50, 1205, 10.1055/a-0759-1629 Zhang, 2020, Liver injury in COVID-19: management and challenges, Lancet Gastroenterol Hepatol, 10.1016/S2468-1253(20)30057-1 Liang, 2020, Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China, Lancet Oncol, 21, 335, 10.1016/S1470-2045(20)30096-6 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 D’Antiga, 2020, Coronaviruses and immunosuppressed patients. The facts during the third epidemic, Liver Transpl, 10.1002/lt.25756 2020 Organización Nacional de Trasplantes. 13/04/2020. REFERENCIA: BV-ES-20200122-8.